KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Non-Current Deffered Revenue (2022 - 2024)

Historic Non-Current Deffered Revenue for Opko Health (OPK) over the last 3 years, with Q3 2024 value amounting to $7000.0.

  • Opko Health's Non-Current Deffered Revenue fell 9485.29% to $7000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $7000.0, marking a year-over-year decrease of 9485.29%. This contributed to the annual value of $7000.0 for FY2023, which is 9492.75% down from last year.
  • Per Opko Health's latest filing, its Non-Current Deffered Revenue stood at $7000.0 for Q3 2024, which was down 9485.29% from $7000.0 recorded in Q2 2024.
  • Opko Health's 5-year Non-Current Deffered Revenue high stood at $140000.0 for Q2 2023, and its period low was $7000.0 during Q4 2023.
  • Its 3-year average for Non-Current Deffered Revenue is $63142.9, with a median of $7000.0 in 2023.
  • Within the past 5 years, the most significant YoY rise in Opko Health's Non-Current Deffered Revenue was 9485.29% (2024), while the steepest drop was 9500.0% (2024).
  • Quarter analysis of 3 years shows Opko Health's Non-Current Deffered Revenue stood at $138000.0 in 2022, then plummeted by 94.93% to $7000.0 in 2023, then changed by 0.0% to $7000.0 in 2024.
  • Its Non-Current Deffered Revenue stands at $7000.0 for Q3 2024, versus $7000.0 for Q2 2024 and $7000.0 for Q1 2024.